| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 43,272 | 73,191 | 64,519 | 35,750 | | Cost of Revenue | 8,684 | 10,428 | 15,368 | 6,870 | | | Gross Profit | 34,588 | 62,763 | 49,151 | 28,880 | | | Operating Expenses | | Research Development | 18,772 | 20,680 | 15,910 | 14,162 | | Selling General and Administrative | 19,767 | 19,373 | 15,975 | 13,864 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,951) | 22,710 | 17,266 | 854 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 432 | 295 | 276 | 352 | | Earnings Before Interest And Taxes | (3,519) | 23,005 | 17,542 | 1,502 | | Interest Expense | 4 | 6 | 4 | 43 | | Income Before Tax | (3,523) | 22,999 | 17,538 | 1,459 | | Income Tax Expense | (2,984) | 9,748 | 7,366 | 4 | | Minority Interest | 1,488 | 2,538 |
-
| 296 | | | | Net Income From Continuing Ops | 949 | 15,789 | 10,172 | 1,455 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 949 | 15,789 | 10,172 | 1,455 | | Preferred Stock And Other Adjustments |
-
| (947) | 947 |
-
| | | Net Income Applicable To Common Shares | $949 | $14,842 | $11,119 | $1,455 |
|
0.21% Nasdaq 
Income Statement
